FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

Feed excerpt — reported by Ars Technica

The risk appears small and data is mixed, but FDA wants patients to be aware.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Ars Technica →

View MAP Context →